Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2000
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054898A1 Neuroprotective peptides and uses thereof
11/29/2000EP1054694A2 Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
11/29/2000EP1054686A1 Pharmaceutical formulation of a didemnin compound
11/29/2000EP1054680A1 Composition and method for the treatment of bladder cancer
11/29/2000EP1054675A1 Regulation of estrus and ovulation in gilts
11/29/2000EP1054674A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/29/2000EP1054672A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
11/29/2000EP1054666A1 Liquid pharmaceutical formulation containing zotepine
11/29/2000EP1054664A1 Method for modulating macrophage activation
11/29/2000EP1054662A1 Water-soluble eye drop
11/29/2000EP1054595A1 Methods and compounds for the genetic treatment of hyperlipidemia
11/29/2000EP0896603B1 Polymer powders redispersible in aqueous solution
11/29/2000EP0862453A4 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275081A Aqueous liquid preparations
11/29/2000CN1275076A Method of administering liposomal encapsulated taxane
11/29/2000CN1274751A Artificial culture of Jiuzhou caterpillar fungus and the application of its sporophore
11/29/2000CN1274579A Method for producing particle with hepatoflavin
11/29/2000CN1274577A Light stable cosmetics barrier compositions
11/29/2000CN1058868C Long-effect and broad-spectrum antibiotic granules and making method of its products thereof
11/28/2000US6153655 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/28/2000US6153653 Choline compositions and uses thereof
11/28/2000US6153644 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/28/2000US6153623 Cisapride extended release
11/28/2000US6153610 For treating cancer tumors
11/28/2000US6153598 Acts as synthetic vector for achieving efficient transfection of associated nucleic acid into a cell; gene therapy
11/28/2000US6153597 For gene therapy such as in vitro, ex vivo and/or in vivo transfer of genetic material
11/28/2000US6153434 Substances are delivered into cells using cationic lipid compounds having a disulfide bond which can be complexed with dna to be inserted into a cell in gene therapy; once inside the cell, enzymes cleave disulfide bond and dna is released
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153225 Injectable formulations of nanoparticulate naproxen
11/28/2000US6153222 A swellable film comprising a mixture of fillers, cleansers, cosmetics, or active substances, film formers, and softeners having portions of a highly absorbent hydrogel former which swells on contact with water; dentifrices
11/28/2000US6153221 Use of biogically active glass as a drug delivery system
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153211 Mixing biologically active drug with a macromer, polymerizing the mixture to form particles, administering the particles for therapeutic treatment
11/28/2000US6153204 Administering a hydrophilic starch esterified with one or more n-octenylsuccinate radicals; degreasing
11/28/2000US6153203 Immunological tolerance-inducing agent
11/28/2000US6153195 Method of delivering drugs to cells specific for an HL-60 lectin
11/28/2000US6153193 Compositions for targeting biological agents
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6153129 Production scale method of forming microparticles
11/28/2000US6152897 Bi-compartment, one-dose syringe comprising a first chamber containing freeze dried mixture of growth hormone, mannitol and an amino acid and a second chamber containing an injectable aqueous reconstitution solution; storage stability
11/28/2000CA2309375A1 Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for steroid
11/28/2000CA2182575C Oil-in-water emulsions
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/27/2000CA2309413A1 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities
11/27/2000CA2309373A1 Novel topical formulations
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000069981A1 A color containing silica resistant to dye migration and method of making the same
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069914A2 Humanized antibodies specific for egp-2
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069887A2 Rapid dehydration of proteins
11/23/2000WO2000069474A1 Methods for treating avm' using radioactive compositions
11/23/2000WO2000069473A2 Macromolecular carrier for drug and diagnostic agent delivery
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069471A1 Enhanced transdermal anesthesia of local anesthetic agents
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069469A1 Topical compositions for prostaglandin e1 delivery
11/23/2000WO2000069440A2 Nicotine delivery systems
11/23/2000WO2000069431A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
11/23/2000WO2000069421A2 Transdermal therapeutic system (tts) containing tolterodine
11/23/2000WO2000069415A2 Melt granulation
11/23/2000WO2000069414A2 Granules containing a plant substance and method for producing the same
11/23/2000WO2000069413A1 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069277A1 A composition containing carvacrol and thymol for use as a bactericide
11/23/2000WO2000051572B1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
11/23/2000WO2000040232A3 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
11/23/2000WO2000036918A9 Methods and compositions for treatment of cell proliferative disorders
11/23/2000WO2000030617A9 Taste masking rapid release coating system
11/23/2000WO2000027430A3 Composition consisting of influenza virus surface proteins and dispensing device
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000019978A3 Compositions and methods for enhancing receptor-mediated cellular internalization
11/23/2000DE19923829A1 Complex of hyaluronate, active ingredient and water, useful as topical pharmaceutical or cosmetic composition, is stable and has high content of active agent
11/23/2000DE19923427A1 Device for improved delivery of active agents to skin, useful e.g. for administering opiates, contains agent that increases local skin temperature or blood flow
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2505617A1 Modified secretin and method of synthesizing thereof
11/23/2000CA2499211A1 Modified peptides yy and conjugates thereof
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2373629A1 Transdermal therapeutic system (tts) containing tolterodine
11/23/2000CA2372435A1 Recombinant human mannan-binding lectin
11/23/2000CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000CA2370245A1 Enzyme-activated anti-tumor prodrug compounds
11/23/2000CA2369983A1 Methods for treating avm's using radioactive compositions
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/23/2000CA2368640A1 A composition containing carvacrol and thymol for use as a bactericide
11/22/2000EP1053746A1 Use of biodegradable microspheres for the delivery of a anticancer agent for the treatment of glioblastoma
11/22/2000EP1053342A2 Nucleic acid delivery vehicles
11/22/2000EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
11/22/2000EP1053282A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation
11/22/2000EP1053238A1 Therapeutic compounds
11/22/2000EP1053029A1 Sterile complex of therapeutic peptide bond to a polysaccharide
11/22/2000EP1053023A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
11/22/2000EP1053022A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
1 ... 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 ... 1712